| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Aug 13, 2019 | AMPH Amphastar Pharmaceuticals, Inc. | Prins Richard K61 | Director | Sell | 10,000 | $20.78 | $207,781.00 | -20.3% | |
| Aug 13, 2019 | ETON Eton Pharmaceuticals, Inc. | Brynjelsen Sean | President &CEO | Buy | 5,000 | $6.15 | $30,750.00 | +0.5% | |
| Aug 13, 2019 | BTAI Bioxcel Therapeutics, Inc. | Yocca Frank88 | Chief Scientific Officer | Buy | 6,547 | $8.67 | $56,762.49 | +353.9% | |
| Aug 13, 2019 | AMPH Amphastar Pharmaceuticals, Inc. | Liawatidewi Yakob47 | SVP Corp Admin Center | Sell | 15,518 | $20.53 | $318,614.63 | -17.5% | |
| Aug 13, 2019 | ANIP Ani Pharmaceuticals Inc | Meridian Venture Partners II LP | 10% Owner | Sell | 61,697 | $71.64 | $4,419,878.37 | -0.9% | |
| Aug 13, 2019 | CPIX Cumberland Pharmaceuticals Inc | Bernard Gordon R | Director | Sell | 6,290 | $5.92 | $37,257.54 | -1.7% | |
| Aug 12, 2019 | DVAX Dynavax Technologies Corp | Cano Francis | Director | Buy | 16,667 | $3.00 | $50,001.00 | New | |
| Aug 12, 2019 | ZTS Zoetis Inc. | Peck Kristin C66 | Executive Vice President | Sell | 11,500 | $123.22 | $1,417,041.28 | -12.6% | |
| Aug 12, 2019 | AQST Aquestive Therapeutics, Inc. | Boyd Peter E.84 | Svp-bus. Process &Info. Tech. | Buy | 600 | $3.81 | $2,286.00 | +1.2% | |
| Aug 12, 2019 | DVAX Dynavax Technologies Corp | Novack David F73 | Co-president And Senior VP | Buy | 16,667 | $3.00 | $50,001.00 | +16.4% | |
| Aug 12, 2019 | TXMD Therapeuticsmd, Inc. | Milligan John C.K. IV | President/ Secretary | Buy | 15,000 | $3.16 | $47,400.00 | +0.4% | |
| Aug 12, 2019 | HROW Harrow, Inc. | Kammer Robert J | - | Sell | 6,500 | $6.89 | $44,785.00 | -0.8% | |
| Aug 12, 2019 | DVAX Dynavax Technologies Corp | Phillips Peggy V | Director | Buy | 16,666 | $3.00 | $49,998.00 | +120.8% | |
| Aug 12, 2019 | TXMD Therapeuticsmd, Inc. | Barlow Jane F | Director | Buy | 3,144 | $3.18 | $9,997.92 | New | |
| Aug 12, 2019 | BHC Bausch Health Companies Inc. | Ackermann Christina | EVP And General Counsel | Sell | 3,418 | $22.45 | $76,725.56 | -6.3% | |
| Aug 9, 2019 | AQST Aquestive Therapeutics, Inc. | Braender Lori J | SVP, General Counsel | Buy | 10,000 | $4.07 | $40,747.00 | +1,000% | |
| Aug 9, 2019 | ETON Eton Pharmaceuticals, Inc. | Casamento Charles J71 | Director | Buy | 3,500 | $6.11 | $21,369.95 | +5.1% | |
| Aug 9, 2019 | PRGO Perrigo Co Plc | Samuels Theodore R. II51 | Director | Buy | 4,000 | $46.97 | $187,892.80 | +52.5% | |
| Aug 9, 2019 | SIGA Siga Technologies Inc | Savas Paul G | Director | Buy | 10,000 | $5.08 | $50,800.00 | +4.0% | |
| Aug 9, 2019 | AQST Aquestive Therapeutics, Inc. | Wood Theresa | Svp-hr And Org. Development | Buy | 1,000 | $3.99 | $3,990.00 | +1.3% | |
| Aug 9, 2019 | TXMD Therapeuticsmd, Inc. | Thompson Tommy G51 | Director | Buy | 5,000 | $3.04 | $15,200.00 | +0.7% | |
| Aug 9, 2019 | TXMD Therapeuticsmd, Inc. | Bernick Brian | Director | Buy | 10,000 | $2.87 | $28,700.00 | +19.2% | |
| Aug 9, 2019 | MRK Merck & Co., Inc. | Deluca Richard R.45 | EVP&Pres, Merck Animal Heallth | Sell | 38,126 | $85.02 | $3,241,638.70 | -21.0% | |
| Aug 9, 2019 | TXMD Therapeuticsmd, Inc. | Finizio Robert G | CEO | Buy | 52,405 | $2.96 | $155,118.80 | +0.3% | |
| Aug 8, 2019 | ANIK Anika Therapeutics, Inc. | Thompson Jeffery S | Director | Sell | 4,843 | $56.66 | $274,404.38 | -41.4% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.